Physician
Ohana Kids & Family Kare LLC
Ohana Kids & Family Kare LLC was paid $4.75M by Medicaid between Apr 2021 and Dec 2024, across 73 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoOHANA KIDS & FAMILY KARE LLC
MESA, AZ 85204
MESA, AZ 85204
33aNPI1003356320assigned 03/06/2017
33bProvider typeFamily Medicine Physician
28Total paid$4.75M
24GClaims106,935
24DCodes billed73
24AFirst – last monthApr 2021 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Arizona
Rank by total paid#24 of 442
Median peer was paid$77K
This provider vs. median62×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 11,193 | $400K | |
| 2022 | 30,786 | $1.49M | |
| 2023 | 34,926 | $1.52M | |
| 2024incomplete | 30,030 | $1.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 26,157 | 22,817 | $1.41M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 13,116 | 11,901 | $985K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 17% | 2,728 | 293 | $787K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.9% | 2,857 | 2,851 | $231K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.7% | 5,409 | 5,315 | $222K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.5% | 2,409 | 2,403 | $213K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.8% | 2,268 | 2,260 | $181K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.0% | 1,937 | 1,904 | $144K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.0% | 1,028 | 1,022 | $95K |
| 92567 | 1.4% | 4,798 | 4,769 | $68K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.1% | 784 | 777 | $54K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 179 | 173 | $36K |
61 more codes
| 99385 | <1% | 335 | $35K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 314 | $29K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,822 | $25K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 732 | $23K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,219 | $22K |
| 99000 | <1% | 3,667 | $18K | |
| 96127 | <1% | 4,170 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,236 | $17K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 484 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,179 | $16K |
| 99173 | <1% | 5,846 | $13K | |
| 92551 | <1% | 1,070 | $11K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 437 | $10K |
| 96160 | <1% | 4,073 | $10K | |
| 95115 | <1% | 1,074 | $10K | |
| 99383 | <1% | 92 | $8K | |
| 99401 | <1% | 191 | $6K | |
| 95117 | <1% | 412 | $5K | |
| 0002A | <1% | 47 | $4K | |
| 99188 | <1% | 362 | $4K | |
| 54450 | <1% | 55 | $4K | |
| 93000 | <1% | 265 | $3K | |
| 81002 | <1% | 1,100 | $3K | |
| 0071A | <1% | 38 | $3K | |
| 99384 | <1% | 27 | $3K | |
| 99382 | <1% | 25 | $2K | |
| 94010 | <1% | 66 | $2K | |
| 99386 | <1% | 13 | $2K | |
| 0072A | <1% | 21 | $1K | |
| 0001A | <1% | 14 | $1K | |
| 99381 | <1% | 13 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 57 | $628.09 |
| 94760 | <1% | 2,190 | $453.36 | |
| 94664 | <1% | 30 | $414.79 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 354 | $391.58 |
| 99408 | <1% | 89 | $311.43 | |
| 81025 | <1% | 26 | $158.78 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 13 | $20.84 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 27 | $5.37 |
| 3077F | 0% | 16 | $0.00 | |
| 90734 | 0% | 331 | $0.00 | |
| 90670 | 0% | 981 | $0.00 | |
| 90633 | 0% | 417 | $0.00 | |
| 90707 | 0% | 27 | $0.00 | |
| 90715 | 0% | 91 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 136 | $0.00 |
| 90671 | 0% | 86 | $0.00 | |
| 3078F | 0% | 13 | $0.00 | |
| 90710 | 0% | 13 | $0.00 | |
| 90696 | 0% | 41 | $0.00 | |
| 90698 | 0% | 345 | $0.00 | |
| 90651 | 0% | 230 | $0.00 | |
| 90677 | 0% | 27 | $0.00 | |
| 90686 | 0% | 275 | $0.00 | |
| 90680 | 0% | 506 | $0.00 | |
| 3074F | 0% | 13 | $0.00 | |
| 90697 | 0% | 227 | $0.00 | |
| 90744 | 0% | 44 | $0.00 | |
| 3008F | 0% | 196 | $0.00 | |
| 90716 | 0% | 44 | $0.00 | |
| 1170F | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOPEZ, LUZ (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Kids Kare Pediatrics PC | Phoenix, AZ | $4.73M |
| DR Grabowski PC | Bellevue, WA | $122K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.